Bis-PEG7-acid is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Bis-PEG6-propionic acid is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
Structure of 94376-75-7
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Bis-PEG7-acid, a polyethylene glycol-based compound, is commonly utilized in bioconjugation and drug delivery. Here are four key applications of Bis-PEG7-acid presented with heightened perplexity and burstiness:
Drug Delivery: Utilizing Bis-PEG7-acid, researchers engineer biocompatible and hydrophilic drug delivery systems. By conjugating it to drugs or therapeutic agents, it enhances their solubility and stability in the bloodstream, thereby potentially boosting the efficacy and bioavailability of treatments, particularly beneficial for hydrophobic drugs.
Bioconjugation: A versatile tool in bioconjugation, Bis-PEG7-acid facilitates the linkage of biomolecules like proteins, peptides, and antibodies, maintaining their biological activity. This compound enables the creation of multifunctional bioconjugates for both research and therapeutic purposes, showcasing its value in advancing biotechnological applications.
Protein Modification: In the realm of protein modification, Bis-PEG7-acid plays a pivotal role in enhancing the pharmacokinetic properties of proteins. By conjugating polyethylene glycol chains to proteins, it can mitigate immunogenicity and prolong their circulation within the body, a critical aspect in the realm of developing protein-based therapeutics for improved patient outcomes.
Polymer Chemistry: With its unique qualities, Bis-PEG7-acid finds utility in polymer chemistry for crafting copolymers and hydrogels with tailored mechanical and chemical characteristics. These materials hold promise for diverse biomedical applications, including tissue engineering and controlled release systems, illustrating the vast potential of this compound in advancing medical technologies.
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-00907 | Bis-PEG8-acid | 1246189-43-4 | |
BADC-00913 | Bis-PEG9-acid | 1268488-70-5 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.